Publicaciones (302) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

2023

  1. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 99-105

  3. Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study

    Reumatologia Clinica, Vol. 19, Núm. 4, pp. 204-210

  4. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  5. Gender biases in Spanish rheumatology: Perception and facts

    Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401

  6. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

    Rheumatology and Therapy, Vol. 10, Núm. 2, pp. 357-373

  7. Neurocientíficas en la Escuela de Cajal: ellas también son Escuela. Fisiología

    Fisiología (Santa Cruz de Tenerife. Ed. impresa), Vol. 25, Núm. 1, pp. 4-9

  8. Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

    Frontiers in Medicine, Vol. 10

  9. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 61

  10. Searching for a prognostic index in lupus nephritis

    European journal of medical research, Vol. 28, Núm. 1, pp. 19

  11. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia

  12. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  2. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  3. Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study

    Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224

  4. Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis

    Immunity and Ageing, Vol. 19, Núm. 1

  5. Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 21

  6. Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin‐1 Serum Levels in Patients with Early Arthritis

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  7. Histological and structural effects of biodegradable polydioxanone stents in the rabbit trachea

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 62, Núm. 2